Elevated soluble urokinase plasminogen activator receptor (suPAR) predicts mortality in Staphylococcus aureus bacteremia

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 30, Issue 11, 2011, Pages 1417-1424

  Molkanen T ^a   Ruotsalainen, E ^a   Thorball, C W ^b   Jarvinen A ^a  

^a HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^b HVIDOVRE HOSPITAL   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; UROKINASE RECEPTOR;

AGED; AREA UNDER THE CURVE; ARTICLE; BACTERIUM IDENTIFICATION; BLOOD CULTURE; CONTROLLED STUDY; DISEASE ASSOCIATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; INFECTION RISK; MALE; MORTALITY; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; PROTEIN DETERMINATION; PROTEIN FUNCTION; RISK ASSESSMENT; STAPHYLOCOCCAL BACTEREMIA; STAPHYLOCOCCUS AUREUS; SURVIVAL RATE;

AGED; BACTEREMIA; BIOLOGICAL MARKERS; CONFIDENCE INTERVALS; FEMALE; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PROGNOSIS; RECEPTORS, UROKINASE PLASMINOGEN ACTIVATOR; SENSITIVITY AND SPECIFICITY; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 80054720119     PISSN: 09349723     EISSN: 14354373     Source Type: Journal    
DOI: 10.1007/s10096-011-1236-8     Document Type: Article

References (40)

1. LO Conterno SB Wey A Castelo 1998 Risk factors for mortality in Staphylococcus aureus bacteremia Infect Control Hosp Epidemiol 19 1 32 37 9475347 10.1086/647704 1:STN:280:DyaK1c7jtlCqtg%3D%3D (Pubitemid 128472660)
2. T Benfield F Espersen N Frimodt-Møller, et al. 2007 Increasing incidence but decreasing in-hospital mortality of adult Staphylococcus aureus bacteraemia between 1981 and 2000 Clin Microbiol Infect 13 3 257 263 17391379 10.1111/j.1469-0691.2006.01589.x 1:STN:280:DC%2BD2s7ptVCgtg%3D%3D (Pubitemid 46603355)
3. JM Mylotte A Tayara 2000 Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort Clin Infect Dis 31 5 1170 1174 11073748 10.1086/317421 1:STN:280:DC%2BD3M%2FotVSmtw%3D%3D (Pubitemid 32295446)
4. VG Fowler Jr MK Olsen GR Corey, et al. 2003 Clinical identifiers of complicated Staphylococcus aureus bacteremia Arch Intern Med 163 17 2066 2072 14504120 10.1001/archinte.163.17.2066 (Pubitemid 37151249)
5. G Fätkenheuer M Preuss B Salzberger, et al. 2004 Long-term outcome and quality of care of patients with Staphylococcus aureus bacteremia Eur J Clin Microbiol Infect Dis 23 3 157 162 14986158 10.1007/s10096-003-1083-3 (Pubitemid 38471419)
6. E Ruotsalainen A Järvinen I Koivula, et al. 2006 Levofloxacin does not decrease mortality in Staphylococcus aureus bacteraemia when added to the standard treatment: a prospective and randomized clinical trial of 381 patients J Intern Med 259 2 179 190 16420547 10.1111/j.1365-2796.2005.01598.x 1:CAS:528:DC%2BD28XisF2qtbo%3D
7. C Pierrakos JL Vincent 2010 Sepsis biomarkers: a review Crit Care 14 1 R15 20144219 10.1186/cc8872
8. SB Yan JD Helterbrand DL Hartman TJ Wright GR Bernard 2001 Low levels of protein C are associated with poor outcome in severe sepsis Chest 120 3 915 922 11555529 10.1378/chest.120.3.915 1:STN:280:DC%2BD3Mrgs1Omsw%3D%3D (Pubitemid 32885469)
9. M Hatzistilianou 2010 Diagnostic and prognostic role of procalcitonin in infections ScientificWorldJournal 10 1941 1946 20890583 10.1100/tsw.2010.181 1:CAS:528:DC%2BC3cXhsVanurrF
10. S Black I Kushner D Samols 2004 C-reactive protein J Biol Chem 279 47 48487 48490 15337754 10.1074/jbc.R400025200 1:CAS:528:DC%2BD2cXpslGqtrw%3D (Pubitemid 39625721)
11. P Póvoa 2002 C-reactive protein: a valuable marker of sepsis Intensive Care Med 28 3 235 243 11904651 10.1007/s00134-002-1209-6 (Pubitemid 34230643)
12. P Póvoa L Coelho E Almeida, et al. 2006 Early identification of intensive care unit-acquired infections with daily monitoring of C-reactive protein: a prospective observational study Crit Care 10 2 R63 16635270 10.1186/cc4892 (Pubitemid 47079868)
13. SM Lobo FR Lobo DP Bota, et al. 2003 C-reactive protein levels correlate with mortality and organ failure in critically ill patients Chest 123 6 2043 2049 12796187 10.1378/chest.123.6.2043 1:CAS:528:DC%2BD3sXlsFCmtbc%3D (Pubitemid 36706731)
14. J Silvestre P Póvoa L Coelho, et al. 2009 Is C-reactive protein a good prognostic marker in septic patients? Intensive Care Med 35 5 909 913 19169668 10.1007/s00134-009-1402-y 1:CAS:528:DC%2BD1MXlt1Kjurk%3D
15. F Blasi P Carmeliet 2002 uPAR: a versatile signalling orchestrator Nat Rev Mol Cell Biol 3 12 932 943 12461559 10.1038/nrm977 1:CAS:528: DC%2BD38XptFKnt7c%3D (Pubitemid 35477371)
16. T Plesner N Behrendt M Ploug 1997 Structure, function and expression on blood and bone marrow cells of the urokinase-type plasminogen activator receptor, uPAR Stem Cells 15 6 398 408 9402652 10.1002/stem.150398 1:CAS:528:DyaK2sXnvFahu7c%3D (Pubitemid 27513714)
17. Q Huai AP Mazar A Kuo, et al. 2006 Structure of human urokinase plasminogen activator in complex with its receptor Science 311 5761 656 659 16456079 10.1126/science.1121143 1:CAS:528:DC%2BD28XptVyltA%3D%3D (Pubitemid 43191309)
18. H De Witte F Sweep N Brünner, et al. 1998 Complexes between urokinase-type plasminogen activator and its receptor in blood as determined by enzyme-linked immunosorbent assay Int J Cancer 77 2 236 242 9650559 10.1002/(SICI)1097-0215(19980717)77:2<236::AID-IJC12>3.0.CO;2-9 (Pubitemid 28287976)
19. CF Sier N Sidenius A Mariani, et al. 1999 Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance Lab Invest 79 6 717 722 10378514 1:STN:280: DyaK1MzgsVymuw%3D%3D (Pubitemid 29283425)
20. JC Garcia-Monco JL Coleman JL Benach 2002 Soluble urokinase receptor (uPAR, CD 87) is present in serum and cerebrospinal fluid in patients with neurologic diseases J Neuroimmunol 129 1-2 216 223 12161038 10.1016/S0165- 5728(02)00186-8 1:CAS:528:DC%2BD38XlvVersLc%3D (Pubitemid 34874926)
21. SR Ostrowski T Piironen G Høyer-Hansen, et al. 2005 High plasma levels of intact and cleaved soluble urokinase receptor reflect immune activation and are independent predictors of mortality in HIV-1-infected patients J Acquir Immune Defic Syndr 39 1 23 31 15851910 10.1097/01.qai. 0000157950.02076.a6 1:CAS:528:DC%2BD2MXjsFKgt7Y%3D (Pubitemid 40617015)
22. B Fevang J Eugen-Olsen A Yndestad, et al. 2009 Enhanced levels of urokinase plasminogen activator and its soluble receptor in common variable immunodeficiency Clin Immunol 131 3 438 446 19232508 10.1016/j.clim.2009.01.007 1:CAS:528:DC%2BD1MXmtVKksbY%3D
23. N Sidenius CF Sier H Ullum, et al. 2000 Serum level of soluble urokinase-type plasminogen activator receptor is a strong and independent predictor of survival in human immunodeficiency virus infection Blood 96 13 4091 4095 11110678 1:CAS:528:DC%2BD3cXosl2hsbg%3D
24. J Eugen-Olsen P Gustafson N Sidenius, et al. 2002 The serum level of soluble urokinase receptor is elevated in tuberculosis patients and predicts mortality during treatment: a community study from Guinea-Bissau Int J Tuberc Lung Dis 6 8 686 692 12150480 1:STN:280:DC%2BD38vgtFOisA%3D%3D (Pubitemid 34832148)
25. CF Sier N Sidenius A Mariani, et al. 1999 Presence of urokinase-type plasminogen activator receptor in urine of cancer patients and its possible clinical relevance Lab Invest 79 6 717 722 10378514 1:STN:280: DyaK1MzgsVymuw%3D%3D (Pubitemid 29283425)
26. CF Sier R Stephens J Bizik, et al. 1998 The level of urokinase-type plasminogen activator receptor is increased in serum of ovarian cancer patients Cancer Res 58 9 1843 1849 9581823 1:CAS:528:DyaK1cXislentr8%3D (Pubitemid 28217457)
27. M Thunø B Macho J Eugen-Olsen 2009 suPAR: the molecular crystal ball Dis Markers 27 3 157 172 19893210
28. S Florquin JG van den Berg DP Olszyna, et al. 2001 Release of urokinase plasminogen activator receptor during urosepsis and endotoxemia Kidney Int 59 6 2054 2061 11380806 1:CAS:528:DC%2BD3MXks1KltLo%3D (Pubitemid 32467596)
29. P Wittenhagen G Kronborg N Weis, et al. 2004 The plasma level of soluble urokinase receptor is elevated in patients with Streptococcus pneumoniae bacteraemia and predicts mortality Clin Microbiol Infect 10 5 409 415 15113317 10.1111/j.1469-0691.2004.00850.x 1:CAS:528:DC%2BD2cXkvFCntrw%3D (Pubitemid 38714567)
30. M Perch P Kofoed TK Fischer, et al. 2004 Serum levels of soluble urokinase plasminogen activator receptor is associated with parasitemia in children with acute Plasmodium falciparum malaria infection Parasite Immunol 26 5 207 211 15491469 10.1111/j.0141-9838.2004.00695.x 1:CAS:528: DC%2BD2cXhtVent7%2FI (Pubitemid 39440864)
31. K Kofoed O Andersen G Kronborg, et al. 2007 Use of plasma C-reactive protein, procalcitonin, neutrophils, macrophage migration inhibitory factor, soluble urokinase-type plasminogen activator receptor, and soluble triggering receptor expressed on myeloid cells-1 in combination to diagnose infections: a prospective study Crit Care 11 2 R38 17362525 10.1186/cc5723 (Pubitemid 46629292)
32. GG Jackson JA Arana-Sialer BR Andersen HG Grieble WR McCabe 1962 Profiles of pyelonephritis Arch Intern Med 110 63 75 13957202 1:STN:280: DyaF387kvV2gug%3D%3D
33. LA Mermel BM Farr RJ Sherertz, et al. 2001 Guidelines for the management of intravascular catheter-related infections Clin Infect Dis 32 9 1249 1272 11303260 10.1086/320001 1:STN:280:DC%2BD3MzpsFansw%3D%3D (Pubitemid 32405897)
34. E Ruotsalainen K Sammalkorpi J Laine, et al. 2006 Clinical manifestations and outcome in Staphylococcus aureus endocarditis among injection drug users and nonaddicts: a prospective study of 74 patients BMC Infect Dis 6 137 16965625 10.1186/1471-2334-6-137 (Pubitemid 44529174)
35. HJ Møller SK Moestrup N Weis, et al. 2006 Macrophage serum markers in pneumococcal bacteremia: prediction of survival by soluble CD163 Crit Care Med 34 10 2561 2566 16915112 10.1097/01.CCM.0000239120.32490.AB (Pubitemid 44413053)
36. UV Schneider RL Nielsen C Pedersen, et al. 2007 The prognostic value of the suPARnostic ELISA in HIV-1 infected individuals is not affected by uPAR promoter polymorphisms BMC Infect Dis 7 134 18021410 10.1186/1471-2334-7-134 (Pubitemid 351187478)
37. P Rabna A Andersen C Wejse, et al. 2009 High mortality risk among individuals assumed to be TB-negative can be predicted using a simple test Trop Med Int Health 14 9 986 994 19725925 10.1111/j.1365-3156.2009.02328.x
38. AF Lomholt IJ Christensen G Høyer-Hansen, et al. 2010 Prognostic value of intact and cleaved forms of the urokinase plasminogen activator receptor in a retrospective study of 518 colorectal cancer patients Acta Oncol 49 6 805 811 20524776 10.3109/0284186X.2010.491086 1:CAS:528: DC%2BC3cXos1KjsLY%3D
39. O Andersen J Eugen-Olsen K Kofoed J Iversen SB Haugaard 2008 Soluble urokinase plasminogen activator receptor is a marker of dysmetabolism in HIV-infected patients receiving highly active antiretroviral therapy J Med Virol 80 2 209 216 18098145 10.1002/jmv.21114 1:CAS:528:DC%2BD1cXhtlyrtb0%3D
40. RW Stephens AN Pedersen HJ Nielsen, et al. 1997 ELISA determination of soluble urokinase receptor in blood from healthy donors and cancer patients Clin Chem 43 10 1868 1876 9342006 1:CAS:528:DyaK2sXmslGhsbg%3D (Pubitemid 27452275)